Tehran Chemie Pharmaceutical Company
Tehran Chemie Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer established in 1957 and listed on Iran Fara Bourse under ticker شتهران. It produces solid oral, liquid, semi-solid and injectable medicines across major therapeutic areas. The company matters to investors and supply-chain counterparties assessing Iranian finished-dose pharmaceutical manufacturing and healthcare demand.
Operations & footprint
Products and services
Tehran Chemie Pharmaceutical Company manufactures finished pharmaceutical dosage forms, generic and branded medicines, and selected pharmaceutical raw materials. Its activity is tied to Iran’s regulated medicine market, domestic healthcare demand, raw-material access, quality-control systems, import-substitution pressure, and supply continuity for prescription and consumer healthcare products.
Operations and assets
The company manufactures solid oral medicines, oral liquids, semi-solid topical products and injectable ampoules. Its portfolio spans several major therapeutic categories, including cardiovascular, anti-infective, CNS, gastrointestinal, respiratory and pain-management medicines.
Geographic footprint
Tehran, Tehran Province, Iran.
Commercial and investment relevance
In the Hormuz investment graph, Tehran Chemie Pharmaceutical Company connects pharmaceutical manufacturing, healthcare consumption, raw-material imports, regulated pricing, quality-control requirements, and medicine supply resilience. It is useful for screening domestic pharma capacity, supplier opportunities, import-substitution pressure, and exposure to defensive healthcare demand. Commercial interpretation should verify current product portfolio, manufacturing licenses, raw-material sourcing, disclosure data, export activity, counterparty risk, and compliance constraints before being treated as actionable intelligence. Tehran Chemie is relevant to pharmaceutical ingredient, excipient, packaging, laboratory, production-equipment and quality-system suppliers seeking relationships with an Iranian finished-dose medicine manufacturer. Its range of oral, topical and injectable forms creates distinct technical and supply requirements across manufacturing lines.
Constraints, risk & compliance
Key risks and constraints
Manufacturing across solid, liquid, semi-solid and injectable dosage forms requires consistent quality control across technically distinct production processes. The breadth of therapeutic coverage also increases portfolio-management and production-planning complexity.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Tehran Chemie Pharmaceutical Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Tehran Chemie Pharmaceutical Company manufacture?
The company manufactures tablets, capsules, syrups, suspensions, creams, ointments, gels and injectable ampoules.
Which therapeutic areas does Tehran Chemie serve?
Its products cover cardiovascular, anti-infective, central nervous system, gastrointestinal, respiratory and pain-management treatment areas.
Is Tehran Chemie Pharmaceutical Company publicly listed?
Yes. The company is listed on Iran Fara Bourse under ticker شتهران.
Where is Tehran Chemie Pharmaceutical Company based?
The company is based in Tehran, Tehran Province, Iran.